Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04741750 · ClinicalTrials.gov registry record · NA

Increasing HCV Linkage to Care Among People Who Inject Drugs

A NA study, sponsored by Family Health Centers of San Diego.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT04741750: Completed NA study, sponsored by Family Health Centers of San Diego.

NCT04741750 is a NA study that has completed, run by Family Health Centers of San Diego. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04741750, a NA study, has completed, sponsored by Family Health Centers of San Diego.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

Our study will test the effectiveness of a simplified approach to delivering Hepatitis C Virus (HCV) care in a street-based mobile medical clinic among people who inject drugs in increasing treatment initiation, retention, and cure. Rates of HCV treatment initiation, retention, and cure will be compared between patients offered the simplified approach to delivering HCV care in a mobile medical clinic versus those who are linked to a community clinic delivering a current practice of usual care. The investigators hypothesize that the simplified approach to delivering HCV care in a street-based mobile medical clinic will result in higher treatment initiation, retention, and cure than the current practice of usual care in community clinics.

Primary Outcome

Initiating treatment with a Direct-Acting Antiviral (DAA)

Interventions

  • OTHER Simplified HCV care within a mobile medical unit

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-02-02
Est. Completion 2023-09-30
Phase NA

What the finished NCT04741750 record still lists

NCT04741750 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Simplified HCV care within a mobile medical unit is the first listed.

NCT04741750 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04741750 about?

NCT04741750 is a clinical study titled "Increasing HCV Linkage to Care Among People Who Inject Drugs". Our study will test the effectiveness of a simplified approach to delivering Hepatitis C Virus (HCV) care in a street-based mobile medical clinic among people who inject drugs in increasing treatment initiation, retention, and cure. Rates of HCV treatment initiation, retention, and cure will be comp...

What is the current status of trial NCT04741750?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2021-02-02. Estimated completion is 2023-09-30.

What interventions are being tested in trial NCT04741750?

The interventions under investigation include: Simplified HCV care within a mobile medical unit (OTHER).

Who is sponsoring clinical trial NCT04741750?

This trial is sponsored by Family Health Centers of San Diego, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04741750's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04741750, the US trial registry maintained by the National Library of Medicine. NCT04741750 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.